Miratas 50 Tablet ER

Composition Mirabegron (50mg)
Rx Prescription Required
Pack strip of 10 tablet er
Storage Store below 30°C
Chemical Class Anilide Derivative
Action Class Selective beta 3-adrenoceptor agonist (Bladder)
Habbit Forming No
Manufacturer Intas Pharmaceuticals Ltd
Manufacturer address Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India.

Miratas 50 Tablet ER is advised to take it in a dose and duration as per prescription. It can be taken with or without food. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.

Some common side effects of this medicine are constipation, headache, high blood pressure, nasal inflammation, and urinary tract infection. If any of the side effects bother you or persist, consult the doctor without delay.

Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.

Treatment of Overactive bladder (OAB) symptoms

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Miratas 50 Tablet ER may be taken with or without food, but it is better to take it at a fixed time.

Miratas 50 Tablet ER is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.

Information not available at the moment. Please check back later.

Miratas 50 Tablet ER helps you to have better control over your urination. It relaxes your bladder which increases its capacity to hold urine thereby reducing the need to pass urine.

It causes less drowsiness and constipation than other medicines for overactive bladder.

It may raise your blood pressure. Monitor your blood pressure regularly.

Do not stop taking this medicine if you do not notice an improvement in your symptoms as it may take some time for your bladder to adapt and your symptoms to improve. 

Q. How long does it take for Miratas 50 Tablet ER to show its effects?

You may see the full benefits of Miratas 50 Tablet ER after 8 weeks of starting the treatment or longer. Depending on how well the medicine suits and affects the patient, the dose can be increased after 4-8 weeks.

Q. Can I stop taking Miratas 50 Tablet ER if I start feeling better?

No, do not stop taking Miratas 50 Tablet ER even if you start feeling better. This medicine does not cure overactive bladder but relieves the symptoms of urgency, frequency and incontinence (unable to control when you empty your bladder). Stopping treatment may result in a recurrence of the symptoms of overactive bladder.

Q. Does Miratas 50 Tablet ER cause loss of sleep?

No, Miratas 50 Tablet ER does not affect your sleep. However, if you are having any problems related to your sleep, talk to your doctor.

Q. What is the effect of Miratas 50 Tablet ER in children?

It is best to avoid the use of Miratas 50 Tablet ER in children because its effectiveness and side effects in children (age < 18 years) have not been studied yet. Q. Can I take Miratas 50 Tablet ER off and on?

No, you need to take it daily as directed by your doctor since it controls your condition and does not cure it. Your bladder takes time to adapt to the medicine, so if you take it off and on, you will not get the desired benefits and your symptoms will recur.

Q. Does Miratas 50 Tablet ER affect the kidneys?

Infection of kidneys, ureters, urinary bladder or urethra is a common side effect of Miratas 50 Tablet ER but does not affect everyone. Very few patients have reported of developing renal stones and bladder pain with the use of Miratas 50 Tablet ER. Also, patients with compromised kidney function should be careful while using Miratas 50 Tablet ER and report any unwanted symptoms related to kidneys to the consulting doctor.

Q. Do I need to be careful while taking Miratas 50 Tablet ER if I am taking medicines to control my blood pressure?

Yes, you need to be careful while taking Miratas 50 Tablet ER if you have high blood pressure. Keep a regular check on your blood pressure since Miratas 50 Tablet ER can cause an increase in blood pressure in some people. It should not be used in patients with severe uncontrolled hypertension.

Q. What if I accidentally take more than the required dose of Miratas 50 Tablet ER?

You should seek urgent medical attention even if do not feel any discomfort. Overdose of Miratas 50 Tablet ER may increase your pulse rate and blood pressure. As a result of this, you may experience severe headache, palpitations, chest pain and fatigue.

In Treatment of Overactive bladder (OAB) symptoms

Miratas 50 Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Urinary tract infection

Nasal inflammation

High blood pressure

Headache

Constipation

Alcohol:CAUTION

Caution is advised when consuming alcohol with Miratas 50 Tablet ER. Please consult your doctor.

Pregnancy:CONSULT YOUR DOCTOR

Miratas 50 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding:CONSULT YOUR DOCTOR

Miratas 50 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving:SAFE

Miratas 50 Tablet ER does not usually affect your ability to drive.

Kidney:CAUTION

Miratas 50 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Miratas 50 Tablet ER may be needed. Please consult your doctor.

Liver:CAUTION

Miratas 50 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Miratas 50 Tablet ER may be needed. Please consult your doctor.Use of Miratas 50 Tablet ER is not recommended in patients with severe liver disease.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 924-25.

Medscape. Mirabegron. view

Mirabegron. Chertsey, Surrey: Astellas Pharma Ltd.; 2012 . view

Mirabegron. Norman, Oklahoma: Astellas Pharma Technologies, Inc; 2012. view